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Background/Aims: Helicobacter pylori causes numerous ex-
tragastric manifestations, including coronary heart disease. 
The coronary artery calciﬁ  cation (CAC) score, measured using 
computed tomography (CT) has been used as a screening 
test for coronary atherosclerosis. This study investigated the 
association between H. pylori seropositivity and CAC scores 
in a screening population. Methods: Patients who underwent 
a health checkup between October 2003 and July 2007 and 
who did not have a history of ischemic heart disease were 
enrolled in the study. Subjects were screened with a multi-
detector CT scan to determine the CAC score and for anti-H. 
pylori antibody immunoglobulin G; traditional risks for coro-
nary heart disease were evaluated using a structured ques-
tionnaire, anthropometric measurements, and laboratory 
tests. Results: Of the 2,029 subjects enrolled (1,295 males), 
1,214 (59.8%) subjects were H. pylori positive and 815 were 
H. pylori negative. There were no significant differences in 
the baseline characteristics of the seropositive and serone-
gative patients. When the CAC presence or absence scores 
were considered, multivariate analysis revealed that H. pylori 
seropositivity was statistically associated with the presence 
of CAC and that this association was stronger in the mild CAC 
score category. Conclusions: H. pylori seropositive patients 
are at a higher risk for coronary atherosclerosis regardless 
of traditional cardiovascular risk factors. This association is 
particularly applicable for early coronary atherosclerosis. (Gut 
Liver 2011;5:321-327)
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INTRODUCTION
Chronic infection with the bacteria Helicobacter pylori can 
cause many gastric diseases, including peptic ulcers and chronic 
gastritis, which can extend to gastric cancers.
1-3 Moreover, it has 
been repeatedly reported that H. pylori infections are associ-
ated with several extragastric conditions, such as cardiovascular 
diseases, pulmonary diseases, neurological diseases and hema-
tological disorders.
4-6 In regards to cardiovascular or cerebro-
vascular diseases, H. pylori infections have been shown to be 
associated with stroke and coronary heart disease as a result of 
the atherosclerotic changes in blood vessels that arise from a 
chronic inflammatory response. However, many of these studies 
have focused on the relationship between overt diseases and H. 
pylori infection.
6-9 
In the case of coronary heart disease, the quiescent gap be-
tween asymptomatic atherosclerotic change and symptomatic 
coronary heart disease should be screened for more aggres-
sively, and practitioners should recommend life style modifica-
tions to patients to reduce the likelihood of further morbidity.
10 
Coronary artery calcium (CAC) levels reported by computed 
tomography (CT) scans are widely accepted as reproducible and 
reliable markers for coronary heart disease risk;
11,12 furthermore, 
CAC score is especially useful for the detection of early stage 
coronary atherosclerosis. According to their CAC score, a sub-
clinical patient can be recommended life style changes and/or 
medication for the effective prevention of coronary heart dis-
ease.
13,14 
The evaluation of H. pylori infection is important for the pro-
motion of the health of the general population, as well as for 
the prevention of coronary heart disease. Measuring serum im-
munoglobulin G antibody to H. pylori is most commonly used 322  Gut and Liver, Vol. 5, No. 3, September 2011
for population-based studies, and its accuracy has been suffi-
ciently established through many studies across a diverse range 
of ethnic groups and countries, including South Korea.
15-17 Even 
though CAC score and H. pylori serology are acceptable tests 
under screening conditions, to the best of our knowledge, there 
have not been any studies that have revealed the relationship 
between H. pylori infection and coronary atherosclerosis using 
these tests. Therefore, we investigated the association between H. 
pylori seropositivity and CAC score in the screening population.
MATERIALS AND METHODS
1. Subjects and ethics
We carried out a retrospective, cross-sectional case-control 
study. Between October 2003 and July 2007, 49,147 subjects 
(26,588 males, 22,559 females) visited the Seoul National Uni-
versity Hospital Healthcare System Gangnam Center for a rou-
tine health check-up. All of the data acquired from the check-
ups were collected through an electronic medical record and 
stored in a data warehouse named HEALTHWATCH
⡴ version 1.0 
(Seoul National University Hospital Healthcare System Gang-
nam Center, Seoul, Korea). We retrieved the data for and en-
rolled 2,029 subjects who had previously undergone their health 
check-ups; which included CAC scores recorded with multi-
detector CT, and serological tests for anti-H. pylori antibody 
immunoglobulin G, both tests had been performed on the same 
day (between October 2003 and July 2007). We excluded the 
subjects who had a history of coronary heart disease or acute 
chest pain.
18 
This study protocol was approved by the Institutional Review 
of Board (IRB) of Seoul National University Hospital (IRB No. 
H-1010-031-335). 
2. Check-up programs in detail
1) A structured questionnaire for the analysis of pertinent 
health and life style factors
The questionnaire consisted of demographic information, 
past and current medical history, socioeconomic status, and a 
systematized review of symptoms including acute chest pain, 
questions on diet, smoking habits (current smokers; defined as 
having smoked greater than or equal to 100 cigarettes in their 
lifetime and who smoked every day or on some days around the 
time of examination)
19 and alcohol consumption (≥140 g/wk or 
≥20 g/day).
20
2) Anthropometric measurements and evaluation for con-
ventional cardiovascular risks
All subjects underwent physical measurements by trained 
personnel with standardized instruments. Body mass index (BMI) 
was calculated from weight and height and then categorized 
according to the modified World Health Organization (WHO) 
criteria from the Asia-Pacific guidelines.
21,22 Waist circumfer-
ence was measured within the WHO recommended area; i.e., the 
midpoint between the lower border of the rib cage and the iliac 
crest.
22 On the same day, after 12 hour fasting, we also mea-
sured blood pressure and performed laboratory tests for levels 
of total cholesterol, triglyceride, high density lipoprotein (HDL) 
cholesterol, fasting serum glucose, glycosylated hemoglobin (he-
moglobin A1c, HbA1c), C-reactive protein (CRP), and uric acid. 
Subjects were classified with metabolic syndrome by the 
presence of three or more of the following criteria: 1) abdominal 
obesity (waist circumference >90 cm in males and >80 cm in 
females, as defined in the Regional Office of the Western Pacific 
Region of World Health Organization (WPRO) waist circumfer-
ence criteria [National Cholesterol Education Program Adult 
Treatment Panel III]); 2) blood pressure (BP) ≥130/85 mm Hg; 3) 
fasting serum glucose ≥100 mg/dL; 4) serum triglyceride ≥150 
mg/dL; 5) HDL-cholesterol <40 mg/dL in males or <50 mg/dL in 
females.
21 
3) Serological test for anti-H. pylori antibody immunoglobu-
lin G 
Anti-H. pylori antibody immunoglobulin G (anti-H. pylori Ab 
Ig G) was measured using an enzyme linked immunosorbent 
assay kit (Radim Diagnostics, Rome, Italy) and an automatic 
analyzer, Alisei
⡴ (Seac, Pomezia, Italy). H. pylori seropositivity 
was determined according to the manufacturer’s instructions.
4) Coronary artery calcium scores recorded using multi-
detector CT 
Scanning of the coronary artery was performed using a 16-
row multi-slice CT scanner (Sensation 16; Siemens Medical Sys-
tems, Erlangen, Germany). Following a topogram of the chest, a 
calcium score scan was performed using a retrospective method 
with a tube voltage of 120 kV, and 110 effective mAs with a 
200 mm field of view.
23 Data were reconstructed to a 3-mm 
slice thickness at a -400 ms acquisition window. Calcium score 
analysis was performed onsite on a dedicated workstation using 
the analysis software Wizard VB10B
⡴ (Somaris/5 VB10B-W, 
SynGo; Siemens). Quantitative CAC scores were calculated ac-
cording to the method described by Agatston et al.
24 
3. Statistical analysis
The continuous variables in this study were expressed as 
means with standard deviations (SD). In between-group com-
parisons, continuous variables were analyzed by Student’s t-test 
and categorical variables by chi-square test. Logistic regression 
analysis was performed to evaluate the statistical significances 
of conventional cardiovascular risk factors and probable vari-
ables on CAC score. Each variable was given as an odds ratio (OR) 
with a 95% confidence interval (CI). A two tailed p-value of 
less than 0.05 was considered statistically significant. Statistical 
analysis was conducted using the SPSS version 12.0 (SPSS Inc., 
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RESULTS
1. Clinical characteristics and CAC score with regards to H. 
pylori seropositivity
A total of 2,029 subjects (1,295 males, 734 females, age 
60.4±7.9) were enrolled in this study. They were divided into 
two groups according to H. pylori-seropositivity; classified as 
either HP-positive (anti-H. pylori Ab Ig G positive) or HP-nega-
tive (anti-H. pylori Ab Ig G negative). There were 1,214 (59.8%) 
HP-positive and 815 (40.2%) HP-negative subjects, respectively.
The clinical characteristics of each H. pylori seropositivity 
group are presented in Table 1. Baseline characteristics were not 
significantly different between HP-positive and HP-negative 
subjects. Moreover, there were no significant differences be-
tween the groups in the prevalence of metabolic syndrome, in 
most of the laboratory tests (except HDL-cholesterol level), and 
in mean CAC scores. The HP-positive group had a significantly 
lower mean HDL-cholesterol level (p=0.010), and a significantly 
higher number of subjects with a CAC score >0 (p=0.037). Dia-
betes was more prevalent in the HP-positive group, but the dif-
ference was not statistically significant (p=0.088).
Mean CAC score was not significantly different between the 
HP-positive and HP-negative groups (p=0.449). The percentile 
distribution of CAC score according to H. pylori seropositivity is 
presented in Table 2. The difference of their means and SD was 
not statistically apparent in these studies since the distribution 
was highly skewed to upper score and its range was from zero 
to 5,060. 
2. Clinical characteristics according to presence of CAC 
score (CAC score >0)
The subjects were divided into two groups according to their 
CAC scores: the absence of a CAC score group (CAC score=0; 
Absence-CAC) and the presence of a CAC score group (CAC 
score >0; Presence-CAC). The clinical characteristics of each 
group are displayed in Table 3. There were 1,269 (62.5%) sub-
jects in the Absence-CAC and 760 (37.5%) in the Presence-
CAC. The presence of a CAC score was significantly associated 
with multiple baseline characteristics such as age (p<0.001), 
sex (p<0.001), smoking (p<0.001), alcohol (p=0.047), diabetes 
(p<0.001), hypertension (p<0.001), BMI (p<0.001), waist cir-
cumference (p<0.001), systolic BP (p<0.001), and diastolic BP 
(p<0.001). From the laboratory parameters, the presence of a 
CAC score was also significantly related to serum triglyceride 
(p<0.001), HDL-cholesterol (p<0.001), fasting glucose (p<0.001), 
HbA1c (p<0.001), uric acid (p<0.001), and H. pylori seroposi-
tivity (p=0.037). Serum total cholesterol (p=0.858) and CRP 
(p=0.224) were not significantly different between the Absence-
CAC and Presence-CAC groups.
Table 1. Comparison of Clinical Characteristics according to H. pylori 
Seropositivity
Characteristic
HP-positive 
(n=1,214)
HP-negative 
(n=815)
p-value 
Age, yr   60.5±7.7  60.3 ±8.2  0.668
Female  427 (35.2)  307 (37.7)  0.251
Smoking 285 (23.5)  178 (21.8)  0.418
Alcohol 119 (9.8) 74 (9.1) 0.588
Diabetes mellitus 199 (16.4)  111 (13.6)  0.088
Hypertension 526 (43.3)  347 (42.6)  0.827
BMI, kg/m
2 24.09±2.75 24.10±2.93 0.887 
  -22.9 410 (33.8) 277 (34.1) 0.986
  23.0-24.9 369 (30.4) 246 (30.3)
  25.0- 435 (35.8) 289 (35.6)
Waist circumference, cm 87.07±8.21  87.26±8.16  0.616 
Systolic BP, mm Hg 123.0±17.4 122.7±17.3 0.690
Diastolic BP, mm Hg 79.7±12.0 79.1±11.9 0.319
Cholesterol, mg/dL  201.3±32.5  201.5±34.7  0.902
Triglyceride, mg/dL  114.6±65.5  116.6±85.9  0.549
HDL-cholesterol, mg/dL  52.4±13.4  54.1±14.1  0.010
Fasting glucose, mg/dL 102.6±22.8  102.1±22.0  0.608
HbA1c, % 5.84±0.75  5.79±0.71  0.149
CRP, mg/L  0.176±0.54  0.167±0.49  0.702 
Uric acid, mg/dL 5.74±1.37  5.76±1.41  0.808
Metabolic syndrome 407 (33.5) 261 (32.0) 0.511
Mean calcium score 71.41±262.63 62.38±264.33 0.449
CAC score>0  477 (39.3) 283 (34.7) 0.037
Data are presented as the mean±SD or number (%).
HP, H. pylori; HP-positive, H. pylori seropositivity; HP-negative, H. 
pylori seronegativity; BMI, body mass index; BP, blood pressure; 
HbA1c, glycosylated hemoglobin, hemoglobin A1c; HDL, high densi-
ty lipoprotein; CRP, C-reactive protein; CAC, coronary artery calcium.
Table 2. Distribution of Coronary Artery Calcium Scores according to 
H. pylori Seropositivity
CAC score
HP-positive
(n=1,214)
HP-negative
(n=815)
p-value*
Mean score  71.41±262.63 62.38±264.33 0.449
Score distribution 
  50th percentile  0 0
  60th percentile  0 0
  75th percentile    25.8   20.0
  80th percentile    43.3   40.1
  90th percentile  160.0 138.5
  95th percentile 346.8 313.3
Data are presented as the mean±SD. 
CAC, coronary artery calcium; HP, H. pylori; HP-positive, H. pylori 
seropositivity; HP-negative, H. pylori seronegativity.
*p-value is from Student’s t-test.324  Gut and Liver, Vol. 5, No. 3, September 2011
3. Univariate and multivariate analyses of the relationship 
between coronary risk factors and the presence of a 
CAC score 
We conducted a logistic regression analysis to test for possi-
ble independent associations between the detected variables and 
the presence of a CAC score; the results are presented in Table 4. 
In the multivariate model, we included the variables that were 
statistically significant in the unadjusted univariate analysis, 
which were: age, sex, BMI, smoking, alcohol, diabetes, hyper-
tension, serum triglyceride, HDL-cholesterol, and H. pylori se-
ropositivity. Among these variables, several were independently 
associated with the presence of a CAC score in the multivariate 
logistic regression analysis. The significant variables (p-value, 
odds ratio with 95% confidence interval) were age (p<0.001; 
OR, 1.10; 95% CI, 1.08 to 1.11), sex (p<0.001; OR, 2.91; 95% CI, 
2.29 to 3.70), H. pylori seropositivity (p=0.049; OR, 1.23; 95% 
CI, 1.001 to 1.51), hypertension (p<0.001; OR, 1.65; 95% CI, 
1.34 to 2.03), diabetes (p=0.003; OR, 1.51; 95% CI, 1.15 to 1.97), 
smoking (p=0.002; OR, 1.49; 95% CI, 1.16 to 1.91), and serum 
triglyceride level (p=0.016; OR, 1.002; 95% CI, 1.000 to 1.003). 
4. Analyses of H. pylori seropositivity against the severity 
categories of CAC score
Multivariate analysis conducted on the categorization of 
Absence-CAC (CAC score=0) and Presence-CAC (CAC score >0) 
verified an independent association between H. pylori seroposi-
tivity and the presence of a CAC score (p=0.049; OR 1.23; 95% 
CI 1.001 to 1.51) (Table 4 and detailed in Table 5). 
To evaluate the association between H. pylori seropositivity 
and CAC score, CAC scores were stratified into four categories 
according to their severities.
12-14 The severity categories were ab-
sence (CAC score=0), mild (0<CAC score≤10), moderate (10<CAC 
score≤100), and severe (100<CAC score). The results of the 
univariate and multivariate analyses of H. pylori seropositivity 
against the CAC severity categories are shown in Table 6. H. 
Table 4. Univariate and Multivariate Analyses of Coronary Risk Fac-
tors and Coronary Artery Calcium Score
Coronary
risk factor
Univariate analysis Multivariate analysis* 
OR (95% CI) p-value OR (95% CI) p-value
Age 1.09 (1.08-1.11) <0.001 1.10 (1.08-1.11) <0.001
Sex
  Female 1.00 1.00
  Male 3.13 (2.54-3.85) <0.001 2.91 (2.29-3.70) <0.001
HP
  HP-negative 
   (referent)
1.00 1.00
  HP-positive 1.22 (1.01-1.46) 0.037 1.23 (1.001-1.51) 0.049
Hypertension
  No (referent) 1.00 1.00
  Yes 2.07 (1.73-2.49) <0.001 1.65 (1.34-2.03) <0.001
Diabetes
  No (referent) 1.00 1.00
  Yes 2.17 (1.70-2.77) <0.001 1.51 (1.15-1.97) 0.003
Alcohol
  No (referent) 1.00 1.00
  Yes 1.36 (1.00-1.83) 0.047 1.16 (0.83-1.61) 0.390
Smoking 
  No (referent) 1.00 1.00
  Yes 1.61 (1.30-1.98) <0.001 1.49 (1.16-1.91) 0.002
Triglyceride 1.003 
(1.001-1.004)
<0.001 1.002 
(1.000-1.003)
0.016
HDL-cholesterol 0.983 
(0.977-0.990)
<0.001 1.00 (0.99-1.01) 0.900
BMI 1.07 (1.04-1.11) <0.001 1.01 (0.97-1.05) 0.626
OR, odds ratio; CI, confidence interval; CAC, coronary artery calcium; 
HP, H. pylori; HP-positive, H. pylori seropositivity; HP-negative, H. 
pylori seronegativity; HDL, high density lipoprotein; BMI, body mass 
index.
*Multivariate model for age, sex, BMI, smoking, alcohol, diabetes, 
hypertension, triglyceride, HDL-cholesterol.
Table 3. Comparison of Clinical Characteristics according to the Score 
for Presence of Coronary Artery Calcium
Characteristic
CAC score>0 
(n=760)
CAC score=0 
(n=1,269)
p-value 
Age, yr 63.6±7.7  58.5±7.4  <0.001 
Male  601 (79.1)  694 (54.7)  <0.001
Smoking  214 (28.2)  249 (19.6)  <0.001
Alcohol    85 (11.2) 108 (8.5) 0.047
Diabetes mellitus  165 (21.7)  145 (11.4)  <0.001
Hypertension  410 (53.9)  463 (36.5)  <0.001
BMI, kg/m
2 24.44±2.69 23.89±2.88  <0.001
  -22.9 209 (27.5) 479 (37.7) <0.001
  23.0-24.9 242 (31.8) 373 (29.4)
  25.0- 309 (40.7) 417 (32.9)
Waist circumference, cm  88.30±8.47  86.46±7.94  <0.001
Systolic BP, mm Hg 126.7±17.8 120.6±16.7 <0.001
Diastolic BP, mm Hg 81.0±12.0 78.5±11.9 <0.001
Cholesterol, mg/dL  201.5±34.4  201.3±32.8  0.858
Triglyceride, mg/dL  124.1±82.3  110.1±68.7  <0.001
HDL-cholesterol, mg/dL  51.2±12.9  54.2±14.0  <0.001
Fasting glucose, mg/dL  107.3±27.7  99.5±18.2  <0.001
HbA1c 6.00±0.87  5.72±0.61  <0.001
CRP, mg/L  0.191±0.51  0.161±0.53  0.224 
Uric acid, mg/dL 6.04±1.37  5.57±1.37  <0.001
HP seropositivity 470 (62.8) 737 (58.1) 0.037
Date are presented as the mean±SD or number (%).
CAC, coronary artery calcium; BMI, body mass index; BP, blood 
pressure; HbA1c, glycosylated hemoglobin, hemoglobin A1c; CRP, C-
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pylori seropositivity was strongly associated with the mild CAC 
category (0<CAC score≤10) (p=0.004; OR, 1.82; 95% CI, 1.22 to 
2.73). However, this association was no longer discernible in the 
progressed CAC score categories: moderate (10<CAC score≤100) 
or severe (100<CAC score). 
DISCUSSION
To the best of our knowledge, this is the first study clarifying 
the association between H. pylori seropositivity and CAC scores 
in a general asymptomatic population. Seropositivity for H. 
pylori antibody G within the study population was significantly 
related to the presence of CAC; especially for the mild CAC 
category, i.e., to early coronary atherosclerosis in asymptomatic 
subjects. Since chronic infections are known to be a predispos-
ing factor for the development of coronary heart disease, there 
has been a continuous effort to investigate the relationship be-
tween H. pylori infection and coronary heart disease.
7,9,25-27 Most 
of the studies have been conducted on diseased subjects and 
only revealed a weak association, which became further con-
fused by multivariate analysis. Furthermore, those studies con-
ducted on young healthy subjects did not find any association 
between H. pylori infection and coronary vessel dysfunction.
28,29 
This might have originated from too many confounding vari-
ables related to the overt disease and the inappropriate selection 
of screening methods during the subclinical stage. CAC scores 
regard the overall burden of coronary atherosclerosis in patients, 
rather than the diagnosis of specific diseased vessels. Therefore, 
categorized CAC scores are currently being used as a guideline 
for suggesting life style changes, for recommendations regard-
ing aspirin consumption and for the monitoring of the health of 
the general population.
13,14 It was not surprising that, H. pylori 
seropositivity was not significantly associated with the manifes-
tation of moderate to severe CAC, since coronary atherosclerosis 
is a multi-factorial disease. However, the strong relationship 
between H. pylori infection and a mild CAC score suggests that 
H. pylori infection can play a role in early atherosclerosis, inde-
pendently, as well as the many traditional risk factors. 
H. pylori infection can cause vascular disease directly, as a 
pathogen of vessel walls,
30,31 or indirectly, through the inflam-
matory process.
32 Regarding inflammation and atherosclerosis 
as a result of H. pylori infection, acute vascular events, such 
as plaque disruption and endothelial desquamation, occur in 
advanced atherosclerotic vessels as a result of the actions of 
various inflammatory markers. In most of the previous studies 
conducted, symptomatic subjects have presented with elevated 
Table 5. Univariate and Multivariate Analyses of H. pylori Seropositivity and Coronary Artery Calcium Score
CAC score
HP-positive (n=1,214)
No. (%) 
HP-negative (n=815)
No. (%) 
Univariate analysis Multivariate analysis* 
OR (95% CI) p-value OR (95% CI) p-value
0 (referent) 737 (60.7) 532 (65.3) 1.00 1.00
>0 477 (39.3) 283 (34.7) 1.22 (1.01-1.46) 0.037 1.23 (1.001-1.51) 0.049
OR, odds ratio; CI, confidence interval; CAC, coronary artery calcium; HP, H. pylori; HP-positive, H. pylori seropositivity; HP-negative, H. pylori 
seronegativity.
*Multivariate model for age, sex, body mass index (BMI), smoking, alcohol, diabetes, hypertension, triglyceride, high density lipoprotein (HDL)-
cholesterol.
Table 6. Univariate and Multivariate Analyses of H. pylori Seropositivity according to Coronary Artery Calcium Score Severity Categories
CAC score
HP-positive (n=1,214)
No. (%)
HP-negative (n=815)
No. (%)
Univariate analysis Multivariate analysis* 
OR (95% CI) p-value OR (95% CI) p-value
Absence
CACS=0
(referent)
737 (60.7) 532 (65.3) 1.00 1.00
Mild
0<CACS≤10
93 (7.7) 37 (4.5) 1.81
(1.22-2.70)
0.003 1.82 
(1.22-2.73)
0.004
Moderate
10<CACS≤100
226 (18.6) 140 (17.2) 1.17
(0.92-1.48)
0.209 1.12
(0.87-1.44)
0.382
Severe
100<CACS
158 (13.0) 106 (13.0) 1.08
(0.82-1.41)
0.595 1.14
(0.83-1.55)
0.424
OR, odds ratio; CI, confidence interval; CAC, coronary artery calcium; HP, H. pylori; HP-positive, H. pylori seropositivity; HP-negative, H. pylori 
seronegativity; CACS, CAC score.
*Multivariate model for age, sex, body mass index (BMI), smoking, alcohol, diabetes, hypertension, triglyceride, high density lipoprotein (HDL)-
cholesterol.326  Gut and Liver, Vol. 5, No. 3, September 2011
levels of inflammatory markers.
26,33,34 In the present study, we 
could not discern the relationship between H. pylori infection, 
and acute vascular events or CRP; therefore, our results neither 
support nor oppose the hypothesis that H. pylori can cause early 
stage atherosclerosis through the inflammatory pathway. The 
significantly lower mean HDL-cholesterol in the HP-positive 
group, compared to the negative group, suggests that endo-
thelial dysfunction might have a relationship with H. pylori 
infection. Indeed, some studies have found lipid profile changes 
and endothelial dysfunction in H. pylori infected subjects;
25,35 
furthermore, in these studies, the lipid profile improved after 
eradication of H. pylori infection.
36,37 
Our study has several advantages over previous clinical 
studies. First, this study was carried out in an asymptomatic 
general population. Usually, studies conducted on symptomatic 
study populations can blur the association between H. pylori 
and coronary heart disease. The subjects enrolled in this study 
were asymptomatic and subclinical, and, therefore, it was pos-
sible to elucidate upon the association between early coronary 
atherosclerosis and H. pylori infection. Second, we selected an 
appropriate screening tool for investigating early coronary ath-
erosclerosis. CAC score, measured using CT, is a well validated 
tool for recording the multiple surrogate markers of coronary 
heart disease among an asymptomatic Korean population.
38 
Third, our health check-up program simultaneously recorded 
the traditional risk factors of coronary heart disease, as well as 
other potential risk factors. Therefore, we could test for covaria-
tion among the traditional risk factors as well as those not yet 
reported. 
There were also limitations to this study. First, there is a gap 
between H. pylori seropositivity and the real ongoing infection. 
Although there have always been debates regarding the gold 
standard tests for H. pylori infection, the serological test for H. 
pylori is the test most commonly adopted in a mass investiga-
tion.
15-17 Second, since this was a cross-sectional study, we could 
not elucidate upon the mechanism by which H. pylori infection 
causes coronary heart disease. To discover this mechanism, we 
need to perform a prospective cohort model study. In addition, 
some cross sectional studies are being designed to investigate 
early atherosclerosis in organs other than coronary vessels.
In conclusion, our study revealed an association between 
H. pylori seropositivity and the presence of a CAC score in the 
subclinical circumstances, and suggested that H. pylori infection 
could be related to the early stages of coronary atherosclerosis 
rather than advanced coronary atherosclerosis.
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